Jean Jacques Bienaime, Director at BioMarin Pharmaceutical, holds 16.61K shares in Immunome (Ticker: IMNM), holds 721.33K shares in BioMarin Pharmaceutical (Ticker: BMRN), holds ― shares in Keros Therapeutics (Ticker: KROS). Most recently, Jean Jacques Bienaime Bought ― shares of Immunome on Aug 19, 2024 for an estimated value of 97.58K.
What is the percentage of profitable transactions made by Jean Jacques Bienaime?
The percentage of profitable transactions made by Jean Jacques Bienaime is 41%.
What is the average return per transaction made by Jean Jacques Bienaime?
The average return per transaction made by Jean Jacques Bienaime is 1.90%.
What stocks does Jean Jacques Bienaime hold?
Jean Jacques Bienaime holds: BMRN, IMNM, KROS, IMUX, INCY, PTLA, NGSX, ITMN stocks.
What was Jean Jacques Bienaime’s latest transaction?
Jean Jacques Bienaime latest transaction was an Informative Buy of $97.58K.
What was Jean Jacques Bienaime's most profitable transaction?
Jean Jacques Bienaime’s most profitable transaction was an Informative Buy of IMUX stock on April 23, 2014. The return on the trade was 138.20%.
What is Jean Jacques Bienaime's role in BioMarin Pharmaceutical?
Jean Jacques Bienaime's role in BioMarin Pharmaceutical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.